Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-25 @ 9:32 PM
Study NCT ID:
NCT00699751
Status:
COMPLETED
Last Update Posted:
2016-05-27
First Post:
2008-06-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06
Start Date Type:
None
Primary Completion Date:
2011-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-17
First Submit QC Date:
None
Study First Post Date:
2008-06-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-06-29
Results First Submit QC Date:
None
Results First Post Date:
2014-05-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-04-27
Last Update Post Date:
2016-05-27
Last Update Post Date Type:
ESTIMATED